Schroder Investment Management Group
TARO

Schroder Investment Management Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Schroder Investment Management Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-84,800
Closed -$6.46M – 1358
2019
Q3 		$6.46M Sell
84,800
-47,800
-36% -$3.88M 0.01% 709
2019
Q2 		$11.3M Buy
132,600
+78,900
+147% +$7.8M 0.01% 687
2019
Q1 		$5.8M Buy
+53,700
New +$5.35M 0.01% 676
2018
Q3 		– Sell
-24,416
Closed -$2.81M – 1348
2018
Q2 		$2.81M Sell
24,416
-233,504
-91% -$25.7M ﹤0.01% 793
2018
Q1 		$25.5M Sell
257,920
-168,535
-40% -$17.1M 0.04% 404
2017
Q4 		$44.7M Sell
426,455
-135,983
-24% -$14.9M 0.07% 312
2017
Q3 		$62.9M Sell
562,438
-118,804
-17% -$12.9M 0.11% 235
2017
Q2 		$76.6M Sell
681,242
-43,260
-6% -$4.89M 0.14% 187
2017
Q1 		$87.2M Sell
724,502
-105,139
-13% -$11.6M 0.16% 177
2016
Q4 		$87.3M Sell
829,641
-38,578
-4% -$4.04M 0.17% 156
2016
Q3 		$95.9M Buy
868,219
+32,100
+4% +$4.25M 0.18% 134
2016
Q2 		$122M Buy
836,119
+142,051
+20% +$20.1M 0.24% 99
2016
Q1 		$98.5M Buy
694,068
+295,727
+74% +$42M 0.2% 121
2015
Q4 		$61.6M Buy
398,341
+95,637
+32% +$14M 0.13% 193
2015
Q3 		$43.3M Buy
302,704
+289,604
+2,211% +$40.5M 0.09% 275
2015
Q2 		$1.86M Buy
+13,100
New +$1.87M ﹤0.01% 840
2014
Q4 		– Sell
-286,038
Closed -$44M – 1501
2014
Q3 		$44M Sell
286,038
-24,762
-8% -$3.73M 0.06% 306
2014
Q2 		$43.6M Buy
+310,800
New +$34.5M 0.05% 305

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Schroder Investment Management Group's TARO Position: Q4 2019 in Review

Schroder Investment Management Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2019, closing a stake of 84,800 shares — an estimated $6.46M sold.

Schroder Investment Management Group first reported a position in TARO in Q2 2014 and held it in 18 quarters. The position peaked at $122M in Q2 2016. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

  • Schroder Investment Management Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2019 after selling out during the quarter.
  • Schroder Investment Management Group sold 84,800 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $6.46M.
  • Schroder Investment Management Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 18 quarters.
  • Schroder Investment Management Group's Taro Pharmaceutical Industries Ltd. position peaked at $122M in Q2 2016.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on Schroder Investment Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.